Dogwood Therapeutics DWTX
NASDAQ DWTX
$1.15 -0.02 (-1.72%)
As of: Oct 22, 2026 · 12:53 PM EDT

Dogwood Therapeutics (DWTX) Non-Current Assets (2024 - 2026)

Updated

Dogwood Therapeutics' Non-Current Assets came in at $69.47 million for Q2 2026, down 15.3% from $81.99 million a year earlier and down 13.4% from the prior quarter.

Analysis

Dogwood Therapeutics (DWTX) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Dogwood Therapeutics' Non-Current Assets was $81.74 million, up 5.1% from FY2024.

  • Going back by year, Non-Current Assets was $77.76 million in FY2024.
  • Business Quant data shows DWTX's Non-Current Assets at $80.2 million (Q1 2026), $81.74 million (Q4 2025) and $80.34 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,166.97 Bn 1,135.56 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 644.38 Bn 564.24 Bn 17.30 Bn 141.07 Bn
3 AbbVie 501.54 Bn 474.65 Bn 12.70 Bn 101.45 Bn
4 Merck 359.36 Bn 313.74 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 302.13 Bn 266.12 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 267.59 Bn 241.28 Bn 12.86 Bn 87.87 Bn
7 Amgen 241.49 Bn 196.89 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn 35.42 Bn
9 Pfizer 171.77 Bn 118.41 Bn 10.94 Bn 159.77 Bn
10 Dogwood Therapeutics 39.25 Mn -240,340.86 - 69.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.47 Mn
Mar 31, 2026 80.20 Mn
Dec 31, 2025 81.74 Mn
Sep 30, 2025 80.34 Mn
Jun 30, 2025 81.99 Mn
Mar 31, 2025 77.82 Mn
Dec 31, 2024 77.76 Mn
API Access

Dogwood Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=DWTX&period=max&api_key=YOUR_API_KEY